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The study protocol was in accordance with the Declaration of Hel-
sinki and approved by the local Ethics Committee. Informed consent
was obtained in all patients before enrollment.
Categorical data are reported as frequencies (percentages) and an-
alyzed by means of χ2 (or Fisher's exact text). Continuous data are
reported as means±SD or medians (95% Confidence Interval — CI)
according to their normal or not normal distribution (Kolmogorov–
Smirnov one-sample normality test) and analyzed by means of Stu-
dent's t-test or Mann–Whitney U-test, respectively. Study population
was divided according to Worsening Renal Function in order to inves-Few data are available on the prognostic role of worsening renal
function (WRF) in patients with ST-elevation myocardial infarction
(STEMI) [1–3]. In patients with systolic dysfunction after MI (SAVE
trial), WRF was associated with increased mortality in patients with-
out renal dysfunction at baseline [4].
No data are available on the prognostic role of WRF in STEMI pa-
tients with preserved ejection fraction.
The present investigation was aimed at assessing the impact of
WRF at short and long term in 681 STEMI patients with preserved
ejection fraction (≥45%, assessed by echocardiography) submitted
to primary percutaneous coronary intervention (PCI) and consecu-
tively admitted to our Intensive Cardiac Care Unit (ICCU) from 1st
January 2004 to 30th June 2010.
On ICCU admission, after PCI, the following parameters were mea-
sured [5–11]: glucose (mg/dl), insulin values (mIU/l), glycated hemo-
globin (HbA1c, %), troponin I (ng/ml), C-reactive protein (mg/dl)
(normal valuesb9), NT-pro Brain Natriuretic Peptide (NT-pro BNP)
(pg/ml), erythrocyte sedimentation rate (ESR), microalbuminuria
(mg/dl), uric acid (mg/dl), leukocytes (*103/μl), fibrinogen (mg/dl).
Glucose, creatinine and Tn I were measured three times a day during
ICCU stay and peak values for each variable were considered. Acute
insulin resistance was measured by means of homeostatic model as-
sessment (HOMA) [5,9–12].nit, Heart and Vessel Depart-
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able logistic regression analysis assessed the relationship between
WRF and ICCU death. Moreover, a multivariable logistic regression
analysis was carried out considering as outcome WRF. Model calibra-
tion was assessed by means of Hosmer–Lemeshow goodness-of-fit
test; Nagelkerke pseudo-R square is also reported. Long time survival
was explored after proportionality of risk assessment, with multivar-
iable Cox regression analysis. In all multivariable analyses, candidate
variables were chosen as those considered clinically relevant or that
showed a univariate relationship with outcome; nonsignificant ones
were dropped by means of backward selection. A two-tailed p
valueb0.05 was considered statistically significant. (SPSS 13.0 statis-
tical package, SPSS Inc, Chicago, IL).
n our series, 88 patients showed WRF (12.9%). Patients who
showed WRF were older (pb0.001), more frequently males
(p=0.002), smokers (p=0.016) and hypertensives (p=0.015). An-
terior myocardial infarction was more frequent in patients with
WRF (p=0.015) who exhibited a higher incidence of higher Killip
classes (pb0.001) and a longer hospitalization (pb0.001). A higher
mortality rate both during ICCU and at follow-up was observed in
WRF patients (pb0.001).
Higher values of NT-pro BNP (pb0.001), uric acid (pb0.001), ESR
(pb0.001), fibrinogen (pb0.001) and a higher incidence of hs-CRP
positivity (p=0.002) were observed in patients with WRF
(Table 1). Ventilatory support (mechanical and non-invasive ventila-
tion), continuous veno-venous hemodiaultrafiltration (CVVHDF) and
intra-aortic balloon pump (IABP) were more frequently used in WRF
patients.
The following variableswere independent predictors for the develop-
ment of WRF: age (1 year step) (OR 1.05, 95%CI 1.01–1.08, p=0.007),
male sex (OR 0.35, 95%CI 0.16–0.76, p=0.008), Killip class III–IV vs. I–II
(OR 8.08, 95%CI 1.25–52.3, p=0.028) and uric acid (1mg/dl step) (ORion with preserved ejection fraction: The impact of worsening renal
Table 1
Laboratory data.
Median (25th to 75th percentile) or frequency (%) p
All patients
n=681
No WRF
n=593 (87.1%)
WRF
n=88 (12.9%)
Admission glucose (mg/dl) 125 (107 to 155) 124 (107 to 153) 130 (108 to 172) 0.130
Peak glycemia (mg/dl) 141 (120 to 177) 140 (120 to 174) 160 (124 to 206) 0.002
Insulin (mU/l) 8.7 (5.2 to 15.8) 8.7 (5.3 to 15.4) 8.9 (4.5 to 17.0) 0.972
HOMA positivity(%) 83 (12.2%) 73 (12.3%) 10 (11.1%) 0.820
Glycated Hb (%) 5.9 (5.6 to 6.3) 5.9 (5.6 to 6.4) 6.0 (5.6 to 6.3) 0.702
Admission creatinine (mg/dl) 0.90 (0.80 to 1.10) 0.90 (0.80 to 1.00) 1.00 (0.72 to 1.30) 0.006
Peak creatinine (mg/dl) 1.00 (0.87 to 1.16) 1.00 (0.80 to 1.10) 1.40 (1.10 to 1.90) b0.001
Discharge creatinine (mg/dl) 0.90 (0.80 to 1.10) 0.90 (0.78 to 1.00) 1.20 (1.00 to 1.70) b0.001
Microalbuminuria (mg/dl) 15.0 (6.2 to 46.5) 14.4 (6.2 to 43.6) 24.8 (6.8 to 87.0) 0.041
Peak Tn I (ng/ml) 59.0 (31.0 to 120.0) 58.4 (30.1 to 114.0) 79.0 (34.2 to 173.7) 0.053
NT-proBNP (pg/ml) 792 (326 to 1583) 673 (310 to 1452) 1854 (1030 to 7783) b0.001
Uric acid (mg/dl) 5.6±1.7 5.5±1.6 6.4±2.2 b0.001
ESR (mm/h) 20 (11 to 35) 19 (10 to 33) 31 (18 to 52) b0.001
Leucocytes (*103/μl) 10.2 (8.2 to 12.6) 10.2 (8.3 to 12.6) 9.5 (7.9 to 12.6) 0.344
hs-CRP positivity (%) 284 (41.7%) 232 (39.2%) 52 (59.4%) 0.002
Fibrinogen (mg/dl) 383 (331 to 452) 380 (329 to 446) 420 (362 to 527) b0.001
WRF: worsening renal failure; HOMA: homeostatic model assessment; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.
2 C. Lazzeri et al. / International Journal of Cardiology xxx (2011) xxx–xxx1.25, 95%CI 1.03–1.52, p=0.024). Admission creatinine (1 mg/dl step)
was not significantly associated (OR 0.96, 95%CI 0.91–4.19, p=0.085).
Hosmer–Lemeshow chi-square 9.04, p=0.339, Nagelkerke pseudo-R2
0.20.
WRF was associated with in-ICCU mortality [unadjusted OR 22.4
(95% CI 5.94–84.5), pb0.001].
At Cox regression analysis, the following variables were indepen-
dently associated with long term mortality: age (1 year step) (HR
1.08, 95%CI 1.06–1.11, pb0.001) and discharge creatinine (1 mg/dl
step) (HR 1.60, 95%CI 1.19–2.14, p=0.002). WRF was not an inde-
pendent predictor of long term mortality.
The main finding of the present investigation, performed in con-
secutive STEMI patients with preserved LVEF submitted to primary
PCI, is that worsening renal function is associated with increased
early death, but not with a poorer survival rate at long term follow-
up.
In our series, the incidence of WRF was not uncommon (12.9%),
being comparable with those reported in patients with MI and systol-
ic dysfunction (12.0%) [2] and in previous investigations enrolling
STEMI patients [15,16].
We documented, for the first time, that in STEMI patients with
preserved LVEF, the development of worsening renal failure identifies
a subset of patients more seriously ill, being older, with more comor-
bidities and a higher hemodynamic derangement (as indicated by
more advanced Killip classes and a higher use of devices). They also
exhibited a worse in-hospital glycemic control (as inferred by peak
glycemia) and a higher inflammatory activation (as indicated by
higher values of hs-CRP, microalbuminuria). These factors are
known to be associated with a worse prognosis at short term in
STEMI patients [5,6,10–12].
Interestingly, in our series, the development ofWRF was related to
a more advanced hemodynamic impairment (as indicated by higher
Killip class), independently of baseline renal function, thus suggesting
the importance of systemic perfusion in the development of kidney
injury. Similarly, Amin et al. [15] reported that left ventricular systolic
dysfunction was independently associated with WRF.
In our series, WRF was not associated with increased mortality at
follow-up, differently from previous studies including also STEMI pa-
tients with systolic dysfunction [15,17].
In conclusion, in a large series of STEMI patients with preserved
LVEF, the development of WRF is associated with higher early mortal-
ity, since it identifies a subset of patients more seriously ill, being
older, with more comorbidities and a higher hemodynamic derange-
ment and inflammatory activation. Overall our data strongly suggest
the clinical need of a close monitoring of renal function in STEMIPlease cite this article as: Lazzeri C, et al, ST-elevation myocardial infarct
failure, Int J Cardiol (2011), doi:10.1016/j.ijcard.2011.11.025patients with preserved LVEF and of a more intensive treatment in
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